You may be surprised to learn that only about 15% of people with hepatitis C are able to fight off the infection without treatment. If you're among the other 85% it's likely that you'll need some form of therapy to regain your health. While several aspects of your infection will affect how treatment will help, the amount of hepatitis C virus in your blood is important in determining whether or not treatment will help you.
PEGINTRON® combination therapy has been proven to be more effective than standard non-pegylated interferon in treating chronic hepatitis C. That means PEGINTRON® combination therapy provides you with a better chance of clearing the virus from your body.
This section explains why the current treatment recommended by the National Institutes of Health for chronic hepatitis C is pegylated alpha interferons and why you should consider choosing a pegylated interferon like PEGINTRON®.
Start Strong, Finish Strong.
PEGINTRON® comes to you from a trusted leader in the field, with unequalled experience in hepatitis C treatment.
How PEGINTRON® Works
Learn why pegylated interferons - like PEGINTRON® combination therapy - stay in your body longer that non-pegylated interferons, and why this is so important to the outcome of your treatment.
Overview of the PEGINTRON® REDIPEN®
Find out why 80% of patients surveyed said that the PEGINTRON® REDIPEN® gives them the features they want in an injection system1.
Features of the PEGINTRON® REDIPEN®
The PEGINTRON® REDIPEN® is designed to be patient-friendly. Learn more about its features and packaging.
How To Use the PEGINTRON® REDIPEN®
Read about the basic steps involved in preparing and injecting the PEGINTRON® REDIPEN® dose.
Key Facts About the PEGINTRON® REDIPEN®
Still not convinced about the benefits of PEGINTRON®? Get answers to some common questions here.
1 Data on file, Schering Corporation.
